相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
Alize J. Ferrari et al.
LANCET PSYCHIATRY (2022)
Impact of bipolar disorder on health-related quality of life and work productivity: Estimates from the national health and wellness survey in Japan
Tadafumi Kato et al.
JOURNAL OF AFFECTIVE DISORDERS (2021)
Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study
Jun Ishigooka et al.
JOURNAL OF AFFECTIVE DISORDERS (2021)
Lurasidone in the long-term treatment of Japanese patients with bipolar I disorder: a 52 week open label study
Teruhiko Higuchi et al.
INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS (2021)
Double-blind,placebo-controlledstudy of lurasidone monotherapy for the treatment of bipolar I depression
Tadafumi Kato et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2020)
Clinical features related to rapid cycling and one-year euthymia in bipolar disorder patients: A multicenter treatment survey for bipolar disorder in psychiatric clinics (MUSUBI)
Masaki Kato et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2020)
Prevalence of mental disorders and mental health service use in Japan
Daisuke Nishi et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2019)
A systematic review and meta-analysis of clinical predictors of lithium response in bipolar disorder
T. P. Hui et al.
ACTA PSYCHIATRICA SCANDINAVICA (2019)
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Maximilian Huhn et al.
LANCET (2019)
Lurasidone: efficacy and safety in the treatment of psychotic and mood disorders
Maurizio Pompili et al.
EXPERT OPINION ON DRUG SAFETY (2018)
Adjunctive Bright Light Therapy for Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Trial
Dorothy K. Sit et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
Lakshmi N. Yatham et al.
BIPOLAR DISORDERS (2018)
Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder
Joseph R. Calabrese et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment
Andrei Pikalov et al.
INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS (2017)
An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression
Suresh Durgam et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY
Terence A. Ketter et al.
DEPRESSION AND ANXIETY (2016)
Antidepressants worsen rapid-cycling course in bipolar depression: A STEP-BD randomized clinical trial
Rif S. El-Mallakh et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
Lurasidone as Adjunctive Therapy With Lithium or Valproate for the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
Antony Loebel et al.
AMERICAN JOURNAL OF PSYCHIATRY (2014)
Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
Antony Loebel et al.
AMERICAN JOURNAL OF PSYCHIATRY (2014)
Rapid Cycling in Bipolar Disorder: A Systematic Review
Andre F. Carvalho et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
A systematic review of the evidence on the treatment of rapid cycling bipolar disorder
Konstantinos N. Fountoulakis et al.
BIPOLAR DISORDERS (2013)
Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder
David E. Kemp et al.
BIPOLAR DISORDERS (2012)
Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression
Mauricio Tohen et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Theo Vos et al.
LANCET (2012)
Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
Kathleen R. Merikangas et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
A Randomized Open Comparison of Long-Acting Injectable Risperidone and Treatment as Usual for Prevention of Relapse, Rehospitalization, and Urgent Care Referral in Community-Treated Patients With Rapid Cycling Bipolar Disorder
William V. Bobo et al.
CLINICAL NEUROPHARMACOLOGY (2011)
Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression
Trisha Suppes et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults With Bipolar Depression (EMBOLDEN II)
Susan L. McElroy et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
A Double-Blind, Placebo-Controlled Study of Quetiapine and Lithium Monotherapy in Adults in the Acute Phase of Bipolar Depression (EMBOLDEN I)
Allan H. Young et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Bipolar disorder with frequent mood episodes in the national comorbidity survey replication (NCS-R)
A. A. Nierenberg et al.
MOLECULAR PSYCHIATRY (2010)
Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity
Tadashi Ishibashi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
The prospective course of rapid-cycling bipolar disorder: Findings from the STEP-BD
Christopher D. Schneck et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Rapid-cycling bipolar I disorder: Course and treatment outcome of a large sample across Europe
N. Cruz et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Quetiapine for the treatment of bipolar II depression: Analysis of data from two randomized, double-blind, placebo-controlled studies
Trisha Suppes et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2008)
Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study
E. Vieta et al.
BIPOLAR DISORDERS (2007)
Efficacy of quetiapine monotherapy in bipolar I and II depression - A double-blind, placebo-controlled study (The BOLDER II study)
Michael E. Thase et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
The use of placebo in clinical trials on bipolar disorder: A new approach for an old debate
E Vieta et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2005)
Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine:: Analysis of pooled data
E Vieta et al.
JOURNAL OF CLINICAL PSYCHIATRY (2004)
The long-term course of rapid-cycling bipolar disorder
W Coryell et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression
P Bech et al.
PSYCHOPHARMACOLOGY (2002)
分享论文
